Zofran lawsuits continue to rise, with most alleging that the drug caused severe birth defects in children born to women who used the drug during pregnancy. Parents in Arkansas, Louisiana, Ohio and Texas have all recently filed birth defect lawsuits against Zofran’s manufacturer, GlaxoSmithKline.
Zofran is an anti-nausea drug used most commonly in post-surgery and cancer patients. However, some doctors have prescribed the drug to treat morning sickness in pregnant women — a use that has allegedly been promoted by GlaxoSmithKline but has not been approved by the U.S. Food and Drug Administration.
Several studies have linked Zofran use during pregnancy to an increased risk of birth defects. Women who have used the drug while pregnant have reported multiple Zofran side effects, including cleft lip and palate defects, heart defects, brain defects and other serious birth defects.